Improving Outcomes for Patients With Metastatic Colorectal Cancer: Challenges and Strategies
Presented by Leslie A. Swanson,(1) ARNP, and Kathleen Boyle,(2) PA-C
From (1)University of Washington/Seattle Cancer Care Alliance; (2)Dana-Farber Cancer Institute, Boston, Massachusetts
Presenters’ disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2020;11(3):291–296 |
© 2020 Harborside™
At JADPRO Live 2019, Leslie A. Swanson, ARNP, and Kathleen Boyle,
PA-C, reviewed guideline-concordant molecular testing and therapy in patients with metastatic colorectal cancer (mCRC), the clinical significance of emerging data for existing and novel agents used to treat mCRC, and the management of adverse events associated with mCRC therapies.
For access to the full length article, please sign in